Lumos Pharma (LUMO) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free LUMO Stock Alerts $3.00 -0.02 (-0.66%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lumos Pharma Short Interest DataCurrent Short Volume286,900 sharesPrevious Short Volume287,500 sharesChange Vs. Previous Month-0.21%Dollar Volume Sold Short$702,905.00Short Interest Ratio / Days to Cover14.3Last Record DateApril 15, 2024Outstanding Shares8,120,000 sharesFloat Size4,920,000 sharesShort Percent of Float5.83%Today's Trading Volume12,524 sharesAverage Trading Volume25,135 sharesToday's Volume Vs. Average50% Short Selling Lumos Pharma ? Sign up to receive the latest short interest report for Lumos Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLUMO Short Interest Over TimeLUMO Days to Cover Over TimeLUMO Percentage of Float Shorted Over Time Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… Lumos Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024286,900 shares $702,905.00 -0.2%5.8%14.3 $2.45 3/31/2024287,500 shares $810,750.00 -2.1%5.9%13.2 $2.82 3/15/2024293,600 shares $792,720.00 -1.4%6.1%13.1 $2.70 2/29/2024297,800 shares $908,290.00 +0.2%6.3%12.5 $3.05 2/15/2024297,200 shares $906,460.00 +2.5%6.3%12.6 $3.05 1/31/2024290,100 shares $818,082.00 +4.9%6.2%2.2 $2.82 Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024276,600 shares $824,268.00 -3.6%5.9%2.1 $2.98 12/31/2023286,900 shares $912,342.00 -0.9%6.1%2.2 $3.18 12/15/2023289,600 shares $825,360.00 -6.7%6.2%2.2 $2.85 11/30/2023310,500 shares $888,030.00 -29.3%6.6%2.4 $2.86 11/15/2023439,200 shares $1.35 million +82.4%9.5%3.4 $3.08 10/31/2023240,800 shares $886,144.00 -6.8%5.2%2.1 $3.68 10/15/2023258,300 shares $1.07 million +11.6%5.6%14.7 $4.16 9/30/2023231,400 shares $763,620.00 -1.4%5.0%12.5 $3.30 9/15/2023234,700 shares $760,428.00 +10.1%5.1%12.3 $3.24 8/31/2023213,200 shares $594,828.00 +3.3%4.5%9.9 $2.79 8/15/2023206,300 shares $608,585.00 +12.6%4.4%8.1 $2.95 7/31/2023183,300 shares $619,554.00 -0.5%3.8%7.3 $3.38 7/15/2023184,300 shares $593,446.00 +3.5%3.8%7.7 $3.22 6/30/2023178,000 shares $587,400.00 +2.2%3.7%8 $3.30 6/15/2023174,200 shares $644,540.00 +0.2%3.6%9.2 $3.70 5/31/2023173,800 shares $637,846.00 +3.2%3.6%10.7 $3.67 5/15/2023168,500 shares $539,200.00 +1.3%3.7%13.6 $3.20 4/30/2023166,400 shares $500,864.00 -2.6%3.7%12.7 $3.01 4/15/2023170,800 shares $577,304.00 -1.6%3.8%12.9 $3.38 3/31/2023173,500 shares $574,285.00 -0.3%3.8%12.4 $3.31 3/15/2023174,100 shares $597,163.00 +0.3%3.8%9.2 $3.43 2/28/2023173,600 shares $597,184.00 +3.0%3.9%7.4 $3.44 2/15/2023168,600 shares $554,694.00 +2.0%3.7%7.4 $3.29 1/31/2023165,300 shares $578,550.00 -27.4%3.5%5.4 $3.50 1/15/2023227,600 shares $910,400.00 -0.7%4.6%8.2 $4.00 12/30/2022229,100 shares $827,051.00 +0.2%4.6%8.4 $3.61 12/15/2022228,600 shares $754,380.00 -0.1%4.6%9 $3.30 11/30/2022228,900 shares $1.17 million +26.9%4.6%10.7 $5.12 11/15/2022180,400 shares $892,980.00 -12.4%3.6%9.9 $4.95 10/31/2022206,000 shares $1.86 million +4.1%4.2%22.6 $9.03 10/15/2022197,900 shares $1.78 million -18.7%4.0%19.2 $9.00 9/30/2022243,500 shares $2.15 million -2.4%5.0%22.8 $8.85 9/15/2022249,600 shares $2.11 million +37.2%5.1%28 $8.47 8/31/2022181,900 shares $1.54 million -0.7%3.7%20.2 $8.47Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. LUMO Short Interest - Frequently Asked Questions What is Lumos Pharma's current short interest? Short interest is the volume of Lumos Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 286,900 shares of LUMO short. 5.83% of Lumos Pharma's shares are currently sold short. Learn More on Lumos Pharma's current short interest. What is a good short interest ratio for Lumos Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LUMO shares currently have a short interest ratio of 14.0. Learn More on Lumos Pharma's short interest ratio. What is a good short interest percentage for Lumos Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.83% of Lumos Pharma's floating shares are currently sold short. Is Lumos Pharma's short interest increasing or decreasing? Lumos Pharma saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 286,900 shares, a decline of 0.2% from the previous total of 287,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lumos Pharma's float size? Lumos Pharma currently has issued a total of 8,120,000 shares. Some of Lumos Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lumos Pharma currently has a public float of 4,920,000 shares. How does Lumos Pharma's short interest compare to its competitors? 5.83% of Lumos Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lumos Pharma: Qilian International Holding Group Limited (0.78%), Oncternal Therapeutics, Inc. (0.52%), Iterum Therapeutics plc (7.50%), Forte Biosciences, Inc. (0.09%), Lisata Therapeutics, Inc. (0.24%), TherapeuticsMD, Inc. (0.41%), Bullfrog AI Holdings, Inc. (5.49%), Biora Therapeutics, Inc. (4.33%), CytoMed Therapeutics Limited (0.99%), Cumberland Pharmaceuticals Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Lumos Pharma stock? Short selling LUMO is an investing strategy that aims to generate trading profit from Lumos Pharma as its price is falling. LUMO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lumos Pharma? A short squeeze for Lumos Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LUMO, which in turn drives the price of the stock up even further. How often is Lumos Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LUMO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Qilian International Holding Group Short Squeeze Oncternal Therapeutics Short Squeeze Iterum Therapeutics Short Squeeze Forte Biosciences Short Squeeze Lisata Therapeutics Short Squeeze TherapeuticsMD Short Squeeze Bullfrog AI Short Squeeze Biora Therapeutics Short Squeeze CytoMed Therapeutics Short Squeeze Cumberland Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LUMO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings